Clinical Trial Agreement Considerations for Pharmaceutical Sponsors

Summary

This practice note provides guidance to attorneys who negotiate and draft clinical trial agreements (CTAs) on behalf of pharmaceutical companies. Pharmaceutical companies, commonly referred to as sponsors in the clinical trial context, often underestimate the importance of spending appropriate time and resources on CTAs. This practice note focuses on key CTA provisions that, if overlooked, can be very costly for organizations.